Pasquale Forgione

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pasquale Forgione. Retrieved from https://idiyas.com/inventor/pasquale-forgione

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 55(Granted Patents)

Company Filing History:

8 out of 1,564

Boehringer Ingelheim International Gmbh

patents

Years Active: 2009-2014

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8912182 - Viral polymerase inhibitors (2014-12-16),

2. 8541402 - Viral polymerase inhibitors (2013-09-24),

3. 8476257 - Viral polymerase inhibitors (2013-07-02),

4. 8067438 - Hepatitis C inhibitor compounds (2011-11-29),

5. 7939667 - Hepatitis C inhibitor compounds (2011-05-10),

6. 7749961 - Macrocyclic peptides active against the hepatitis C virus (2010-07-06),

7. 7705146 - Hepatitis C inhibitor peptide analogs (2010-04-27),

8. 7585845 - Hepatitis C inhibitor compounds (2009-09-08),

Title: Pasquale Forgione: Innovator in Viral Polymerase Inhibitors

Introduction

Pasquale Forgione is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of viral polymerase inhibitors. With a total of 8 patents to his name, Forgione's work has the potential to impact the treatment of viral infections, including hepatitis C.

Latest Patents

Among his latest patents, Forgione has developed compounds that serve as inhibitors of the hepatitis C virus NS5B polymerase. These compounds are defined by a specific formula, wherein various components are tailored to enhance their efficacy against the virus. His innovative approach in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Forgione has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Forgione has had the opportunity to work alongside talented individuals such as Montse Llinas-Brunet and Jean Rancourt. These collaborations have enriched his research and fostered an environment of innovation and creativity.

Conclusion

Pasquale Forgione's contributions to the field of viral polymerase inhibitors highlight his role as a key innovator in medicinal chemistry. His patents and collaborations reflect a dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.